| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $1.31B | +23.6% |
| Cost of Revenue | $195.9M | +8.8% |
| Gross Profit | $1.11B | +26.6% |
| R&D Expense | $332.1M | +16.2% |
| SG&A Expense | $231.6M | -3.3% |
| Operating Income | -$164.7M | +52.7% |
| Pre-tax Income | -$75.8M | +76.1% |
| Income Tax | $14.1M | +30.4% |
| Net Income | -$89.9M |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.06B | -24.3% |
| Short-term Investments | $818.1M | +130.6% |
| Accounts Receivable | $436.3M | +16.6% |
| Current Assets | $2.58B | +10.1% |
| Total Assets | $2.95B | +8.0% |
| Current Liabilities | $711.7M | +13.6% |
| Total Liabilities | $938.6M | +15.2% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $299.1M | +3096.5% |
| Capital Expenditures | $7.3M | -69.2% |
| Investing Cash Flow | -$439.6M | -52.0% |
| Financing Cash Flow | -$196.9M | -224.5% |
| Free Cash Flow | $291.7M | +963.2% |
| +72.6% |
| EPS (Basic) | -$0.16 | +73.3% |
| EPS (Diluted) | -$0.16 | +73.3% |
| Stockholders' Equity |
| $2.02B |
| +5.0% |